🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Laura Chambers

Cleveland Clinic

ORCID: 0000-0002-3773-7060

Also affiliated with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy?”.

Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy?

Gynecologic Oncology(2020)10.1016/j.ygyno.2019.12.028
N/A
0DataRank · unranked
19 citations

Ting‐Tai Yen, Rebecca L. Stone, Stephanie L. Wethington, Caitlin Carr, Ji Son +24 more

Disruption of the Gut Microbiota Attenuates Epithelial Ovarian Cancer Sensitivity to Cisplatin Therapy

Research Square(2020)10.21203/rs.3.rs-80626/v1
N/A
0DataRank · unranked
2 citations

Emily Esakov, Chad Braley, Lexie Trestan, Zahraa Alali, Peter Bazeley +13 more

Disruption of the gut microbiota attenuates epithelial ovarian cancer sensitivity to cisplatin therapy

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.16.155226
N/A
0DataRank · unranked
1 citations

Emily Esakov, Chad Braley, Lexie Trestan, Zahraa Alali, Defne Bayık +14 more

Disruption of the Gut Microbiota Attenuates Epithelial Ovarian Cancer Sensitivity to Cisplatin Therapy

Research Square(2021)10.21203/rs.3.rs-80626/v2
N/A
0DataRank · unranked
2 citations

Emily Esakov, Chad Braley, Lexie Trestan, Zahraa Alali, Defne Bayık +14 more

High pre-treatment neutrophil-to-lymphocyte ratio as a prognostic marker for worse survival in patients with recurrent/metastatic cervical cancer treated with immune checkpoint inhibitors

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.101040
N/A
0DataRank · unranked
7 citations

David A. Mix Barrington, Morgan Brown, Lynette Gonzalez, Jae Suk Baek, Allison Huffman +10 more

The Role of the Microbiome in Cancer Therapies

Hematology/Oncology Clinics of North America(2025)10.1016/j.hoc.2024.12.005
N/A
0DataRank · unranked
4 citations

Naomi E. Goldstein, Yogita Mehra, Daniel Spakowicz, Laura Chambers, Julia Chalif

Assessment of readability of gynecologic cancer clinical trials literature at National Cancer Institute–designated Comprehensive Cancer Centers

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2025.101693
N/A
0DataRank · unranked
1 citations

Wafa Khadraoui, John L. Hays, Larry J. Copeland, Roberto Vargas, David M. O’Malley +2 more

Exploratory evaluation of immunotherapy response and medication use in endometrial and cervical carcinoma

Gynecologic Oncology Reports(2025)10.1016/j.gore.2025.101782
N/A
0DataRank · unranked
0 citations

Molly Morton, Eric McLaughlin, Anna Gonzalez, Jessica Fulton, Jessica Sciuva +11 more